TOKYO, May 12 (Reuters) - Japan’s third-largest drugmaker Daiichi Sankyo forecast an annual profit far below market expectations, hit by losses linked to its new subsidiary Ranbaxy Laboratories, sending its shares tumbling 9 percent.
TOKYO, May 12 (Reuters) - Japan’s third-largest drugmaker Daiichi Sankyo forecast an annual profit far below market expectations, hit by losses linked to its new subsidiary Ranbaxy Laboratories, sending its shares tumbling 9 percent.
